Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer

Published:2019-02-05 Issue:6 Volume:123 Page:959-967
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

D'Andrea David¹^ORCID,Soria Francesco¹²^ORCID,Zehetmayer Sonja³,Gust Kilian M.¹,Korn Stephan¹,Witjes J. Alfred⁴,Shariat Shahrokh F.¹⁵⁶

Affiliation:

1. Department of Urology; Medical University of Vienna; Vienna Austria

2. Department of Urology; University of Turin; Turin Italy

3. Centre for Medical Statistics, Informatics and Intelligent Systems; Medical University of Vienna; Vienna Austria

4. Department of Urology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

5. Department of Urology; University of Texas Southwestern Medical Center; Dallas TX USA

6. Department of Urology; Weill Cornell Medical College; New York NY USA

Funder

Nucleix, Rehovot, Israel

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14673/fullpdf

Reference27 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

2. Economic burden of bladder cancer across the European Union;Leal;Eur Urol,2016

3. ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers;Kamat;Eur Urol,2013

4. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder;Karakiewicz;BJU Int,2006

5. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma;Lotan;Urol Oncol,2017

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docsubty: SSUA review on trends in development and translation of omics signatures in cancer;Computational and Structural Biotechnology Journal;2024-02

2. Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result;Biomedicines;2023-12-12

3. Recommendations for Cell-Free DNA Assay Validations;The Journal of Molecular Diagnostics;2023-12

4. The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review;Diagnostics;2023-10-03

5. Experiencia inicial y propuesta de seguimiento del tumor de vejiga no músculo infiltrante de alto riesgo mediante el uso de Bladder Epicheck®;Actas Urológicas Españolas;2023-10